Re-Engaging AYA Survivors in Cancer-Related Healthcare (NCT07138040) | Clinical Trial Compass
RecruitingNot Applicable
Re-Engaging AYA Survivors in Cancer-Related Healthcare
United States530 participantsStarted 2025-08-01
Plain-language summary
The goal of this clinical trial is to test the efficacy (how well they work) of different digital interventions that deliver information to adolescent and young adult (AYA) survivors of childhood cancer to promote re-engagement in cancer-related long-term follow-up care (LTFU). The main aims are:
* To test the efficacy of adaptive interventions (AIs) that begin with low touch intervention (LTI) as compared to written information (WI) on attending an appointment, and self-reported self-management among AYA.
* To identify the most efficacious second-stage strategy for those who initially schedule/attend an appointment (maintenance vs. step-up) and for those who do not (step-up vs. step-up maximum).
* To assess multilevel factors contributing to the effects of re-engaging AYA and how best to integrate AIs into practice.
Throughout the duration of the study, participants will complete four surveys, receive a series of interventions, and may be asked to participate in an interview (post-intervention).
Who can participate
Age range15 Years – 29 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. 15-29 years old
✓. History of a childhood cancer diagnosis, diagnosed prior to age 22
✓. Has not had a cancer-related follow-up visit in at least 15 months (or is 3 months past recommended follow-up)
✓. U.S. resident (not international patient)
✓. Has previously attended a cancer-related appointment at Children's Hospital of Philadelphia, or Nationwide Children's Hospital or Penn
✓. At least 2 years from end of treatment and 5 years from diagnosis
✓. English proficient
✓. For AYA under age 18, must have a caregiver to provide informed consent